Cost efficiency in caring for patients with febrile neutropenia
Research type
Research Study
Full title
Cost efficiency in caring for patients with febrile neutropenia and comparison of quality of life.
IRAS ID
232353
Contact name
Faye Marshall
Contact email
Sponsor organisation
City Hospitals Sunderland
Duration of Study in the UK
1 years, 0 months, 1 days
Research summary
The study is to compare the standard of care for patients with Febrile neutropenia (which is a serious complication of chemotherapy) with an alternative interventional approach. Patients are usually treated as inpatients but emerging evidence suggests that patients can be effectively treated as outpatients. The study will compare the cost of care, and quality of life, for patients with low risk febrile neutropenia, treated in a standard inpatient setting, versus those treated on an ambulatory care pathway.
REC name
North West - Greater Manchester West Research Ethics Committee
REC reference
18/NW/0834
Date of REC Opinion
19 Dec 2018
REC opinion
Unfavourable Opinion